immunosuppressive therapy
Showing 1 - 25 of >10,000
Severe Aplastic Anemia Trial in Tianjin (Cyclophosphamide added to standard immunosuppressive therapy with eltrombopag)
Recruiting
- Severe Aplastic Anemia
- Cyclophosphamide added to standard immunosuppressive therapy with eltrombopag
-
Tianjin, Tianjin, ChinaRegenerative Medicine Center
Jul 27, 2023
Severe Aplastic Anemia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Sirolimus)
Recruiting
- Severe Aplastic Anemia
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Mindfullnes-Based Cognitive Therapy and Adherence to Immunosuppressive Therapy Trial in Malatya (Mindfullnes-Based Cognitive
Completed
- Mindfullnes-Based Cognitive Therapy and Adherence to Immunosuppressive Therapy
- Mindfullnes-Based Cognitive Therapy
-
Malatya, Turkeythe Liver Transplant Hospital affiliated with Turgut Özal Medica
Aug 10, 2023
Glomerulonephritis, IGA Trial (Prednisolone, Prednisolone plus Cyclophosphamide)
Not yet recruiting
- Glomerulonephritis, IGA
- Prednisolone
- Prednisolone plus Cyclophosphamide
- (no location specified)
Aug 19, 2022
Lupus Nephritis, Remission, Safety Issues Trial in Nanjing (Methylprednisolone Injectable Suspension, Belimumab Injection,
Recruiting
- Lupus Nephritis
- +2 more
- Methylprednisolone Injectable Suspension
- +2 more
-
Nanjing, Jiangsu, ChinaJiong Zhang
May 8, 2023
Anti-HLA Immunization And Immunosuppressive Therapy Management
Active, not recruiting
- Kidney Transplantation
- +3 more
- management of immunosuppressive therapy
-
Nancy, Lorraine, FranceCentral HNF
Mar 24, 2022
Severe Aplastic Anemia (SAA) Trial (Romiplostim, Antithymocyte Globulin, Cyclosporine A)
Not yet recruiting
- Severe Aplastic Anemia (SAA)
- Romiplostim
- +2 more
- (no location specified)
Sep 2, 2022
Sickle Cell Disease Trial in Duarte (Hematopoietic stem cell transplantation)
Recruiting
- Sickle Cell Disease
- Hematopoietic stem cell transplantation
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 14, 2022
Thrombotic Thrombocytopenic Purpura Trial (Caplacizumab, Corticosteroids, anti-CD20 antibody)
Not yet recruiting
- Thrombotic Thrombocytopenic Purpura
- Caplacizumab
- +2 more
- (no location specified)
Aug 8, 2022
Severe Aplastic Anemia Who Relapsed After Immunosuppressive
Active, not recruiting
- Severe Aplastic Anemia
-
Bethesda, MarylandNational Heart, Lung and Blood Institute (NHLBI)
Apr 7, 2022
Kidney Injury, Kidney Failure, Kidney Failure, Chronic Trial in Washington (AlloSure, PAXGene)
Suspended
- Kidney Injury
- +9 more
- AlloSure
- PAXGene
-
Washington, District of ColumbiaGeorge Washington University
Feb 16, 2023
Solid Organ Transplant Rejection, Organ Rejection Transplants, Organ Rejection Trial (Bone Marrow Mesenchymal Stem Cell Derived
Not yet recruiting
- Solid Organ Transplant Rejection
- +2 more
- Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment
- (no location specified)
Aug 16, 2022
Adult Patients With Chronic Primary ITP, Adult Patients With SAA Who do Not Respond Well to Immunosuppressive Therapy Trial
Not yet recruiting
- Adult Patients With Chronic Primary ITP
- Adult Patients With SAA Who do Not Respond Well to Immunosuppressive Therapy
- Herombopag Olamine Tablets
- (no location specified)
Sep 28, 2023
Vogt Koyanagi Harada Disease Trial in São Paulo (Early high-dose corticosteroid and immunosuppressive therapy)
Recruiting
- Vogt Koyanagi Harada Disease
- Early high-dose corticosteroid and immunosuppressive therapy
-
São Paulo, SP, BrazilHospital das Clinicas HCFMUSP, Faculdade de Medicina Universidad
Jan 4, 2022
Severe Aplastic Anemia Who Developed High Risk Clonal Evolution
Completed
- Severe Aplastic Anemia
-
Bethesda, MarylandNational Heart, Lung and Blood Institute (NHLBI)
Apr 7, 2022
Multiple Sclerosis Trial in Saint Petersburg (Fludarabine Phosphate for Injection)
Recruiting
- Multiple Sclerosis
- Fludarabine Phosphate for Injection
-
Saint Petersburg, Russian FederationFirst Pavlov State Medical University of St. Petersburg
Apr 14, 2023
Chronic GVHD Trial in Seattle (Immunosuppressive Therapy, Survey Administration)
Completed
- Chronic Graft Versus Host Disease
- Immunosuppressive Therapy
- Survey Administration
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 22, 2021
COVID-19 Trial in Australia (diphtheria and tetanus toxoids (adsorbed) vaccine, COVID-19 vaccine)
Not yet recruiting
- COVID-19
- diphtheria and tetanus toxoids (adsorbed) vaccine
- COVID-19 vaccine
-
Blacktown, New South Wales, Australia
- +4 more
Nov 20, 2022
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, End Stage Renal Disease Trial in France (Discontinuation (or not
Recruiting
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- End Stage Renal Disease
- Discontinuation (or not initiation) of Immunosuppressive Therapy
- Maintenance (or initiation) of immunosuppressive treatment: Imurel®, Mabthera®,Cellcept®, Cortancyl®
-
Amiens, France
- +54 more
Jan 6, 2023
Autoimmune Rheumatologic Disease Trial in Calgary (Avaxim Pediatric®, Avaxim ® (adult))
Recruiting
- Autoimmune Rheumatologic Disease
- Avaxim Pediatric®
- Avaxim ® (adult)
-
Calgary, Alberta, CanadaAlberta Children's Hospital/University of Calgary
Oct 2, 2021
Aplastic Anemia Trial in Assiut (Combination of thrombopoietin mimetic and cyclosporin A)
Completed
- Aplastic Anemia
- Combination of thrombopoietin mimetic and cyclosporin A
-
Assiut, EgyptAssiut university hospital Internal Medicine Department Hematolo
Sep 28, 2021
Aplastic Anemia Trial in Kanazawa, Tokyo, Seoul (Romiplostim)
Completed
- Aplastic Anemia
- Romiplostim
-
Kanazawa, Japan
- +2 more
Feb 4, 2022
Severe Aplastic Anemia Trial in Shanghai (Thymoglobulin, Cord blood, Cyclosporine Oral Product)
Recruiting
- Severe Aplastic Anemia
- Thymoglobulin
- +2 more
-
Shanghai, Shanghai, ChinaShanghai general hospital, Shanghai Jiaotong university school o
Oct 10, 2021